Cargando…

Comment on: Høeg et al. Lipid-Induced Insulin Resistance Affects Women Less Than Men and Is Not Accompanied by Inflammation or Impaired Proximal Insulin Signaling. Diabetes 2011;60:64–73

Detalles Bibliográficos
Autor principal:	Cusi, Kenneth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Online Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161319/ https://www.ncbi.nlm.nih.gov/pubmed/21868787 http://dx.doi.org/10.2337/db11-0687

Ejemplares similares

Response to Comment on: Høeg et al. Lipid-Induced Insulin Resistance Affects Women Less Than Men and Is Not Accompanied by Inflammation or Impaired Proximal Insulin Signaling. Diabetes 2011;60:64–73
por: Kiens, Bente, et al.
Publicado: (2011)

Comment on: Ferrannini. Learning From Glycosuria. Diabetes 2011;60:695–696
por: Stanton, Robert C.
Publicado: (2011)

Response to Comment on: Ferrannini. Learning From Glycosuria. Diabetes 2011;60:695–696
por: Ferrannini, Ele
Publicado: (2011)

Comment on: Ott et al. Reduction in Basal Nitric Oxide Activity Causes Albuminuria. Diabetes 2011;60:572–576
por: Tsikas, Dimitrios, et al.
Publicado: (2011)

Response to Comment on: Ott et al. Reduction in Basal Nitric Oxide Activity Causes Albuminuria. Diabetes 2011;60:572–576
por: Ott, Christian, et al.
Publicado: (2011)

Comment on: Maruthur et al. Does Genetic Ancestry Explain Higher Values of Glycated Hemoglobin in African Americans? Diabetes 2011;60:2434–2438
por: Dagogo-Jack, Samuel
Publicado: (2012)

Response to Comment on: Maruthur et al. Does Genetic Ancestry Explain Higher Values of Glycated Hemoglobin in African Americans? Diabetes 2011;60:2434–2438
por: Maruthur, Nisa M., et al.
Publicado: (2012)

Comment on: Atkinson. It's Time to Consider Changing the Rules: The Rationale for Rethinking Control Groups in Clinical Trials Aimed at Reversing Type 1 Diabetes. Diabetes 2011;60:361–363
por: Sanda, Srinath, et al.
Publicado: (2011)

Comment on: Kim et al. Deficiency for Costimulatory Receptor 4-1BB Protects Against Obesity-Induced Inflammation and Metabolic Disorders. Diabetes 2011;60:3159–3168
por: Gomez-Mejiba, Sandra E., et al.
Publicado: (2012)

Comment on: Berhan. Thirty Years of Prospective Nationwide Incidence of Childhood Type 1 Diabetes: The Accelerating Increase by Time Tends to Level Off in Sweden. Diabetes 2011;60:577–581
por: Howard, Sarah G.
Publicado: (2011)

Response to Comment on: Atkinson. It's Time to Consider Changing the Rules: The Rationale for Rethinking Control Groups in Clinical Trials Aimed at Reversing Type 1 Diabetes. Diabetes 2011;60:361–363
por: Atkinson, Mark A.
Publicado: (2011)

Response to Comment on: Kim et al. Deficiency for Costimulatory Receptor 4-1BB Protects Against Obesity-Induced Inflammation and Metabolic Disorders. Diabetes 2011;60:3159–3168
por: Yu, Rina
Publicado: (2012)

Erratum. Mediobasal Hypothalamic SIRT1 Is Essential for Resveratrol’s Effects on Insulin Action in Rats. Diabetes 2011;60:2691–2700
por: Knight, Colette M., et al.
Publicado: (2017)

Influence of Gut Microbes on the Brain-Gut Axis (Gut 2011;60:307-317)
por: Lee, Yeong Yeh, et al.
Publicado: (2011)

Lipid-Induced Insulin Resistance Affects Women Less Than Men and Is Not Accompanied by Inflammation or Impaired Proximal Insulin Signaling
por: Høeg, Louise D., et al.
Publicado: (2011)

Acute Tryptophan Depletion and Functional Brain Imaging in Irritable Bowel Syndrome (Gut 2011;60:1196-1203)
por: Kim, Hee Man
Publicado: (2012)

Identification of metabolic modifiers that underlie phenotypic variations in energy-balance regulation. Diabetes 2011;60:726–734
por: Chang, CL, et al.
Publicado: (2013)

Erratum. APPL1 Counteracts Obesity-Induced Vascular Insulin Resistance and Endothelial Dysfunction by Modulating the Endothelial Production of Nitric Oxide and Endothelin-1 in Mice. Diabetes 2011;60:3044–3054
por: Wang, Yi, et al.
Publicado: (2016)

Statement of Retraction. Physical Exercise Reduces Circulating Lipopolysaccharide and TLR4 Activation and Improves Insulin Signaling in Tissues of DIO Rats. Diabetes 2011;60:784–796. DOI: 10.2337/db09-1907
por: Oliveira, Alexandre G., et al.
Publicado: (2016)

Expression of Concern. Prep1 Controls Insulin Glucoregulatory Function in Liver by Transcriptional Targeting of SHP1 Tyrosine Phosphatase. Diabetes 2011;60:138–147. DOI: 10.2337/db10-0860. PMID: 20864515
por: Oriente, Francesco, et al.
Publicado: (2018)

Erratum. Abrogation of MMP-9 Gene Protects Against the Development of Retinopathy in Diabetic Mice by Preventing Mitochondrial Damage. Diabetes 2011;60:3023–3033
por: Kowluru, Renu A., et al.
Publicado: (2021)

Effects of Proximal Gut Bypass on Glucose Tolerance and Insulin Sensitivity in Humans
por: Breitman, Igal, et al.
Publicado: (2013)

Could Carbon Breath Test Measurement Accurately Reflect Gastric Emptying of Liquid Nutrient Meal in the Critically Ill Patients? (Gut 2011;60:1336-1343)
por: Kim, Ji Won
Publicado: (2012)

Increased expression and activity of 12-lipoxygenase in oxygen-induced ischemic retinopathy and proliferative diabetic retinopathy: implications in retinal neovascularization. Diabetes 2011;60:614–624
por: Al-Shabrawey, M, et al.
Publicado: (2013)

Statement of Retraction. Hepatic Glucagon Action Is Essential for Exercise-Induced Reversal of Mouse Fatty Liver. Diabetes 2011;60:2720–2729. DOI: 10.2337/db11-0455
por: Berglund, Eric D., et al.
Publicado: (2016)

Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age
por: Hurley, Donald, et al.
Publicado: (2020)

List of PH I Experiments 73-64
por: CERN. Geneva. Electronic Experiments Committee
Publicado: (1973)

Insulin Autoimmune Syndrome: 73 Cases of Clinical Analysis
por: Wang, Yun-Lin, et al.
Publicado: (2015)

Insulin Glulisine May Cause a Disease Resembling Insulin Autoimmune Syndrome: Case Report
por: Kawasaki, Maki, et al.
Publicado: (2013)

Comment on: Tessari et al. Roles of Insulin, Age, and Asymmetric Dimethylarginine on Nitric Oxide Synthesis In Vivo. Diabetes 2013;62:2699–2708
por: Kruszelnicka, Olga, et al.
Publicado: (2013)

Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140–2147
por: Home, Philip D.
Publicado: (2013)

Immunologic Tolerance to the Insulin Analogue Glulisine
por: Ozaki, Nobuaki, et al.
Publicado: (2010)

Response to Comment on: Tessari et al. Roles of Insulin, Age, and Asymmetric Dimethylarginine on Nitric Oxide Synthesis In Vivo. Diabetes 2013;62:2699–2708
por: Tessari, Paolo
Publicado: (2013)

Response to Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140–2147
por: Bergenstal, Richard M., et al.
Publicado: (2013)

Ultra fast miniaturized real-time PCR: 40 cycles in less than six minutes
por: Neuzil, Pavel, et al.
Publicado: (2006)

Comment on: Tam et al. Defining Insulin Resistance From Hyperinsulinemic-Euglycemic Clamps. Diabetes Care 2012;35:1605–1610
por: Færch, Kristine, et al.
Publicado: (2013)

Comment on: Tam et al. Defining Insulin Resistance From Hyperinsulinemic-Euglycemic Clamps. Diabetes Care 2012;35:1605–1610
por: Davidson, Mayer B.
Publicado: (2013)

Analysis of the Outcomes of 73 Patients with Exogenous Positive Insulin Anti-Body
por: Yao, Dan, et al.
Publicado: (2022)

Insulin degludec and insulin glargine 300 U/mL: Which of these two insulins causes less hypoglycemia?
por: Buscemi, Silvio, et al.
Publicado: (2019)

Comment on: Schuit et al. β-Cell–Specific Gene Repression: A Mechanism to Protect Against Inappropriate or Maladjusted Insulin Secretion? Diabetes 2012;61:969–975
por: Rutter, Guy A., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_nsuc85sq7q41s6bc90ecbcv0oh